Wells Fargo’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.78M | Buy |
83,071
+52,744
| +174% | +$3.81M | ﹤0.01% | 2555 |
|
|
2026
Q1 | $2.07M | Sell |
30,327
-56,594
| -65% | -$4.01M | ﹤0.01% | 3238 |
|
|
2025
Q4 | $6.6M | Buy |
86,921
+35,478
| +69% | +$2.58M | ﹤0.01% | 2405 |
|
|
2025
Q3 | $3.16M | Buy |
51,443
+7,506
| +17% | +$391K | ﹤0.01% | 2969 |
|
|
2025
Q2 | $2.15M | Buy |
43,937
+4,582
| +12% | +$218K | ﹤0.01% | 3171 |
|
|
2025
Q1 | $2.01M | Buy |
39,355
+1,207
| +3% | +$60.2K | ﹤0.01% | 3155 |
|
|
2024
Q4 | $1.72M | Buy |
38,148
+11,499
| +43% | +$492K | ﹤0.01% | 3309 |
|
|
2024
Q3 | $989K | Sell |
26,649
-4,188
| -14% | -$140K | ﹤0.01% | 3553 |
|
|
2024
Q2 | $943K | Buy |
30,837
+3,232
| +12% | +$105K | ﹤0.01% | 3533 |
|
|
2024
Q1 | $803K | Buy |
27,605
+2,193
| +9% | +$61.4K | ﹤0.01% | 3590 |
|
|
2023
Q4 | $700K | Sell |
25,412
-27,886
| -52% | -$638K | ﹤0.01% | 3644 |
|
|
2023
Q3 | $1.19M | Sell |
53,298
-10,044
| -16% | -$374K | ﹤0.01% | 3202 |
|
|
2023
Q2 | $2.58M | Buy |
63,342
+23,436
| +59% | +$1.15M | ﹤0.01% | 2699 |
|
|
2023
Q1 | $1.93M | Buy |
39,906
+38,763
| +3,391% | +$1.77M | ﹤0.01% | 2896 |
|
|
2022
Q4 | $43.6K | Sell |
1,143
-1,867
| -62% | -$77.6K | ﹤0.01% | 4920 |
|
|
2022
Q3 | $151K | Sell |
3,010
-815
| -21% | -$39.9K | ﹤0.01% | 4390 |
|
|
2022
Q2 | $154K | Sell |
3,825
-34,236
| -90% | -$1.2M | ﹤0.01% | 4418 |
|
|
2022
Q1 | $1.42M | Sell |
38,061
-22,544
| -37% | -$869K | ﹤0.01% | 3595 |
|
|
2021
Q4 | $2.41M | Buy |
60,605
+2,994
| +5% | +$115K | ﹤0.01% | 3302 |
|
|
2021
Q3 | $2.14M | Buy |
57,611
+11,869
| +26% | +$488K | ﹤0.01% | 3611 |
|
|
2021
Q2 | $1.93M | Sell |
45,742
-22,439
| -33% | -$961K | ﹤0.01% | 3723 |
|
|
2021
Q1 | $3.23M | Sell |
68,181
-16,579
| -20% | -$985K | ﹤0.01% | 3268 |
|
|
2020
Q4 | $5.17M | Buy |
84,760
+18,633
| +28% | +$1.1M | ﹤0.01% | 2721 |
|
|
2020
Q3 | $3.09M | Sell |
66,127
-102,531
| -61% | -$5.05M | ﹤0.01% | 2963 |
|
|
2020
Q2 | $8.56M | Buy |
168,658
+45,750
| +37% | +$2.25M | ﹤0.01% | 1990 |
|
|
2020
Q1 | $5.48M | Buy |
122,908
+85,264
| +227% | +$4.29M | ﹤0.01% | 2160 |
|
|
2019
Q4 | $1.81M | Sell |
37,644
-67
| -0.2% | -$2.85K | ﹤0.01% | 3423 |
|
|
2019
Q3 | $1.27M | Buy |
37,711
+3,770
| +11% | +$164K | ﹤0.01% | 3659 |
|
|
2019
Q2 | $1.53M | Sell |
33,941
-55,414
| -62% | -$2.19M | ﹤0.01% | 3557 |
|
|
2019
Q1 | $3.36M | Buy |
89,355
+1,356
| +2% | +$45.5K | ﹤0.01% | 2923 |
|
|
2018
Q4 | $3.02M | Buy |
87,999
+52,250
| +146% | +$1.88M | ﹤0.01% | 2927 |
|
|
2018
Q3 | $1.68M | Sell |
35,749
-95,082
| -73% | -$3.93M | ﹤0.01% | 3550 |
|
|
2018
Q2 | $4.41M | Buy |
130,831
+51,475
| +65% | +$1.61M | ﹤0.01% | 2809 |
|
|
2018
Q1 | $2.15M | Buy |
79,356
+3,199
| +4% | +$81.1K | ﹤0.01% | 3326 |
|
|
2017
Q4 | $1.27M | Buy |
76,157
+23,164
| +44% | +$392K | ﹤0.01% | 3757 |
|
|
2017
Q3 | $1.06M | Sell |
52,993
-732
| -1% | -$14.3K | ﹤0.01% | 3810 |
|
|
2017
Q2 | $985K | Sell |
53,725
-9,721
| -15% | -$131K | ﹤0.01% | 3744 |
|
|
2017
Q1 | $625K | Sell |
63,446
-8,209
| -11% | -$99.4K | ﹤0.01% | 4096 |
|
|
2016
Q4 | $782K | Buy |
71,655
+33,477
| +88% | +$351K | ﹤0.01% | 3886 |
|
|
2016
Q3 | $535K | Buy |
38,178
+8,491
| +29% | +$69K | ﹤0.01% | 3918 |
|
|
2016
Q2 | $209K | Sell |
29,687
-1,880
| -6% | -$13.8K | ﹤0.01% | 4383 |
|
|
2016
Q1 | $202K | Sell |
31,567
-1,435,331
| -98% | -$24.9M | ﹤0.01% | 4408 |
|
|
2015
Q4 | $47.5M | Sell |
1,466,898
-443,633
| -23% | -$13.1M | 0.02% | 792 |
|
|
2015
Q3 | $51M | Buy |
1,910,531
+317,171
| +20% | +$13.6M | 0.02% | 736 |
|
|
2015
Q2 | $76.7M | Buy |
1,593,360
+595,852
| +60% | +$34.8M | 0.03% | 619 |
|
|
2015
Q1 | $60.7M | Buy |
997,508
+644,893
| +183% | +$39.3M | 0.02% | 696 |
|
|
2014
Q4 | $18.3M | Buy |
352,615
+311,067
| +749% | +$13.7M | 0.01% | 1346 |
|
|
2014
Q3 | $1.83M | Buy |
41,548
+37,992
| +1,068% | +$1.19M | ﹤0.01% | 3057 |
|
|
2014
Q2 | $92K | Buy |
3,556
+317
| +10% | +$6.79K | ﹤0.01% | 4717 |
|
|
2014
Q1 | $84K | Buy |
3,239
+239
| +8% | +$6.42K | ﹤0.01% | 4730 |
|
|
2013
Q4 | $51K | Sell |
3,000
-25,733
| -90% | -$452K | ﹤0.01% | 4742 |
|
|
2013
Q3 | $617K | Buy |
+28,733
| New | +$499K | ﹤0.01% | 3642 |
|
Other funds holding PTCT
RI
JT
Wells Fargo's PTCT Position: Q2 2026 in Review
Wells Fargo increased its PTC Therapeutics (PTCT) stake by 174% in Q2 2026, buying an estimated $3.81M and bringing the position to 83,071 shares worth $6.78M. The position accounts for ﹤0.01% of the portfolio, ranked #2555.
Wells Fargo first reported a position in PTCT in Q3 2013 and has held it in 52 quarters since. The position peaked at $76.7M in Q2 2015. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.
- Wells Fargo held 83,071 shares of PTC Therapeutics worth $6.78M as of Q2 2026.
- Wells Fargo bought 52,744 PTC Therapeutics shares in Q2 2026, an estimated $3.81M.
- PTC Therapeutics made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #2555 holding.
- Wells Fargo first reported a position in PTC Therapeutics in Q3 2013 and has held it in 52 quarters since.
- Wells Fargo's PTC Therapeutics position peaked at $76.7M in Q2 2015.
- 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.
Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.